Mothaffar F. Rimawi
Baylor College of Medicine(US)Children's Cancer Center(US)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function(2008)492 cited
- → TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer(2012)491 cited
- → A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models(2013)481 cited
- → TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases(2019)336 cited
- → Towards personalized treatment for early stage HER2-positive breast cancer(2019)291 cited
- → Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation(2011)282 cited